Cost-Consequence Analysis of an Aprepitant Regimen Versus a Standard Antiemetic Regimen for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting in Italy
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2222
https://www.valueinhealthjournal.com/article/S1098-3015(14)04152-7/fulltext
Title :
Cost-Consequence Analysis of an Aprepitant Regimen Versus a Standard Antiemetic Regimen for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting in Italy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04152-7&doi=10.1016/j.jval.2014.08.2222
First page :
A625
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1681